Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

HistoSonics

Explore full profile

Non-invasive tumor destruction using focused ultrasound

Minneapolis, United StatesFounded 2009Health Tech & Medtech
Valuation $2.5–5B Last recorded · 2026
Revenue $100–500M Latest reported FY
Headcount 100–500 Current team size
Total funding $500M–1B Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for HistoSonics and the history behind them.

About HistoSonics

HistoSonics is pioneering a non-invasive, robotically assisted platform that utilizes focused sound energy to mechanically destroy diseased tissue at a sub-cellular level. The company operates in the medical technology sector, primarily serving healthcare providers and patients. HistoSonics' core technology, known as histotripsy, offers a non-ionizing and non-thermal treatment option, making it a safer alternative to traditional methods. The business model revolves around the development and commercialization of its proprietary platform, Edison™, which provides real-time treatment monitoring and procedural control. Revenue is generated through the sale of the Edison™ platform and associated services, including clinical trials and ongoing support. HistoSonics is currently conducting clinical trials in the United States and Europe under the HOPE4LIVER initiative, aiming to bring this innovative treatment to a broader market.

Source: Dealroom company data

At a glance

Founded
2009
Headquarters
Minneapolis, United States
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Research & analysis

From the Dealroom knowledge graph
News Synektik CEO sells 7.2% stake for 215M zł after 1,500% share surge Aug 21, 2026 News HistoSonics raises growth equity at $3.75B valuation, backed by Reed Jobs' Yosemite Jun 22, 2026 News Petal Surgical adds more funding for incisionless surgical robot Jun 2, 2026

Latest news

Press, funding announcements and product moves mentioning HistoSonics.

See all news

Investors

26 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • Venture Investors Health Fund
  • Fletcher Spaght, Inc.
  • Hatteras Venture Partners
  • TGap Ventures
  • Fletcher Spaght Ventures
  • Early Stage Partners
  • UM-MINTS

Series B and later19 investors entered at this stage

  • Grand Rapids Business Journal
  • Grand Angels
  • Capital Community Angel Investors
  • HistoSonics
  • Varian Medical Systems
  • Johnson & Johnson Innovation
  • Lumira Ventures
  • State of Wisconsin Investment Board
  • Yonjin Venture
  • Signature Bank
  • Alpha Wave Global
  • HealthQuest Capital
  • Amzak Health
  • Wellington Management
  • Thiel Bio
  • K5 Global
  • Bezos Expeditions
  • Yosemite
  • Reed Jobs

Talent

Book a demo to see the people
Employees mapped 429 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇺🇸 United States95.6%
🇷🇸 Serbia1.9%
🇪🇸 Spain0.6%
🇸🇬 Singapore0.6%
🇦🇪 United Arab Emirates0.3%
Top 5 of 8 shown
Web traffic by country
13K monthly visits
across markets
🇺🇸 United States53.1%
🇨🇦 Canada21.5%
🇬🇧 United Kingdom13.8%
🇮🇳 India4.6%
🇭🇰 Hong Kong3.8%
Top 5 markets shown

Patents

Estimated portfolio value
$19M

36 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about HistoSonics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See HistoSonics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles